341 related articles for article (PubMed ID: 23666469)
1. Update on oxalate crystal disease.
Lorenz EC; Michet CJ; Milliner DS; Lieske JC
Curr Rheumatol Rep; 2013 Jul; 15(7):340. PubMed ID: 23666469
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review.
Demoulin N; Aydin S; Gillion V; Morelle J; Jadoul M
Am J Kidney Dis; 2022 May; 79(5):717-727. PubMed ID: 34508834
[TBL] [Abstract][Full Text] [Related]
3. Late presentation and microcrystalline arthropathy in primary hyperoxaluria.
Verbruggen LA; Bourgain C; Verbeelen D
Clin Exp Rheumatol; 1989; 7(6):631-3. PubMed ID: 2612083
[TBL] [Abstract][Full Text] [Related]
4. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.
Geraghty R; Wood K; Sayer JA
Urolithiasis; 2020 Oct; 48(5):377-384. PubMed ID: 32719990
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow oxalosis with pancytopenia in a patient with short bowel syndrome: Report of a case and review of the literature.
Bering JL; Wiedmeier-Nutor JE; Sproat L; DiBaise JK
JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):165-170. PubMed ID: 36181457
[TBL] [Abstract][Full Text] [Related]
6. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
Langman CB; Assimos D; Blank M; Calle J; Grauer A; Kausz A; Milliner D; Nazzal L; Smith K; Tasian G; Thompson A; Wood KD; Worcester E; Yang S; Malley MA; Knauf F; Lieske JC;
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1637-1644. PubMed ID: 37342976
[TBL] [Abstract][Full Text] [Related]
7. A hidden cause of oxalate nephropathy: a case report.
Mahmoud T; Ghandour EC; Jaar BG
J Med Case Rep; 2021 Mar; 15(1):106. PubMed ID: 33678172
[TBL] [Abstract][Full Text] [Related]
8. Oxalate crystal deposition disease.
Maldonado I; Prasad V; Reginato AJ
Curr Rheumatol Rep; 2002 Jun; 4(3):257-64. PubMed ID: 12010612
[TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease.
Hoffman GS; Schumacher HR; Paul H; Cherian V; Reed R; Ramsay AG; Franck WA
Ann Intern Med; 1982 Jul; 97(1):36-42. PubMed ID: 7092004
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
Bollée G; Cochat P; Daudon M
Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104
[TBL] [Abstract][Full Text] [Related]
11. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
[TBL] [Abstract][Full Text] [Related]
12. The management of patients with enteric hyperoxaluria.
Asplin JR
Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
[TBL] [Abstract][Full Text] [Related]
13. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
[TBL] [Abstract][Full Text] [Related]
14. [Oxalate: from physiology to pathology].
Grocholski C; Derain Dubourg L; Guebre-Egziabher F; Acquaviva-Bourdain C; Abid N; Bacchetta J; Chambrier C; Lemoine S
Nephrol Ther; 2023 Jun; 19(3):201-214. PubMed ID: 37166780
[TBL] [Abstract][Full Text] [Related]
15. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.
Marschner JA; Mulay SR; Steiger S; Anguiano L; Zhao Z; Boor P; Rahimi K; Inforzato A; Garlanda C; Mantovani A; Anders HJ
Front Immunol; 2018; 9():2173. PubMed ID: 30319631
[TBL] [Abstract][Full Text] [Related]
16. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
[TBL] [Abstract][Full Text] [Related]
17. Secondary hyperoxaluria due to pancreatic insufficiency.
de Martines DGL; Gianotten S; F M Wetzels J; G van der Meijden WA
Neth J Med; 2019 Oct; 77(8):287-292. PubMed ID: 31814577
[TBL] [Abstract][Full Text] [Related]
18. Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.
Hueppelshaeuser R; von Unruh GE; Habbig S; Beck BB; Buderus S; Hesse A; Hoppe B
Pediatr Nephrol; 2012 Jul; 27(7):1103-9. PubMed ID: 22366809
[TBL] [Abstract][Full Text] [Related]
19. Purslane-induced oxalate nephropathy: case report and literature review.
Wang X; Zhang X; Wang L; Zhang R; Zhang Y; Cao L
BMC Nephrol; 2023 Jul; 24(1):207. PubMed ID: 37443012
[TBL] [Abstract][Full Text] [Related]
20. Palmar papules as a manifestation of cutaneous oxalosis in primary hyperoxaluria: A case report and review of the literature.
Alabdullah H; Soqia J; Douri T
Clin Case Rep; 2024 Jan; 12(1):e8423. PubMed ID: 38188849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
